<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neurosurgery Blog &#187; Uncategorized</title>
	<atom:link href="http://www.neurosurgery-blog.com/archives/category/uncategorized/feed" rel="self" type="application/rss+xml" />
	<link>http://www.neurosurgery-blog.com</link>
	<description>Daily bibliographic and video review of the Neurosurgery Department. La Fe University Hospital. Valencia, Spain</description>
	<lastBuildDate>Thu, 09 Feb 2012 23:00:45 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Hardware-related infections after deep brain stimulation surgery: review of incidence, severity and management in 212 single-center procedures in the first year after implantation</title>
		<link>http://www.neurosurgery-blog.com/archives/3600</link>
		<comments>http://www.neurosurgery-blog.com/archives/3600#comments</comments>
		<pubDate>Thu, 29 Dec 2011 23:00:26 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Deep Brain Stimulation]]></category>
		<category><![CDATA[Deep brain stimulation complications]]></category>
		<category><![CDATA[Device-related infections]]></category>
		<category><![CDATA[Hardware complications]]></category>
		<category><![CDATA[Surgical complications]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3600</guid>
		<description><![CDATA[Acta Neurochir (2011) 153:2337–2341. DOI 10.1007/s00701-011-1130-2
Device-related infection is a common occurrence after deep brain stimulation (DBS) surgery, and may result in additional interventions and a loss of efficacy of therapy. This retrospective review aimed to evaluate the incidence, severity and management of device-related infections in 212 DBS procedures performed in our institute.
Methods Data on 106 [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/12/deep-brain-stimulation-surgery1.jpg"><img class="alignleft size-thumbnail wp-image-3605" title="deep brain stimulation surgery" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/12/deep-brain-stimulation-surgery1-150x150.jpg" alt="" width="150" height="150" /></a>Acta Neurochir (2011) 153:2337–2341. DOI 10.1007/s00701-011-1130-2</strong></p>
<p style="text-align: justify;">Device-related infection is a common occurrence after deep brain stimulation (DBS) surgery, and may result in additional interventions and a loss of efficacy of therapy. This retrospective review aimed to evaluate the incidence, severity and management of device-related infections in 212 DBS procedures performed in our institute.</p>
<p style="text-align: justify;">Methods Data on 106 patients, in whom 212 DBS procedures were performed between 2001 and 2011 at our institute by a single neurosurgeon (M.P.), were reviewed to assess the incidence, severity, management and clinical characteristics of infections in the first year after the implantation of a DBS system.</p>
<p style="text-align: justify;">Results Infections occurred in 8.5% of patients and 4.2% of procedures. Of the nine infections, eight involved the neurostimulator and extensions, and one the whole system. The infections occurred 30.7 days after implantation: 7 within 30 days and 2 within 6 months. Infected and uninfected patients were comparable in terms of age, sex, indication for DBS implantation and neurostimulator location. In eight cases, the system components involved were removed and re-implanted after 3 months, while in one case the complete hardware was removed and not re-implanted.</p>
<p style="text-align: justify;">Conclusion The overall incidence of postoperative infections after DBS system implantation was 4.2%; this rate decreased over time. All infections required further surgery. Correct and timely management of partial infections may result in successful salvage of part of the system.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3600/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Typical 3-D localization of tumor remnants of WHO grade II hemispheric gliomas—lessons learned from the use of intraoperative high-field MRI control</title>
		<link>http://www.neurosurgery-blog.com/archives/2316</link>
		<comments>http://www.neurosurgery-blog.com/archives/2316#comments</comments>
		<pubDate>Fri, 11 Mar 2011 05:00:12 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Grade II glioma]]></category>
		<category><![CDATA[Intraoperative MRI]]></category>
		<category><![CDATA[Neuronavigation]]></category>
		<category><![CDATA[Tumor remnant]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2316</guid>
		<description><![CDATA[Acta Neurochir (2011) 153:479–487. DOI 10.1007/s00701-010-0911-3
Complete resection of grade II gliomas might prolong survival but is not always possible. The goal of the study was to evaluate the location of unexpected grade II gliomas remnants after assumed complete removal with intraoperative (iop) MRI and to assess the reason for their non-detection.
Methods Intraoperative MR images of [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/03/tumor_remnants.jpg"><img class="alignleft size-thumbnail wp-image-2319" title="tumor_remnants" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/03/tumor_remnants-150x150.jpg" alt="" width="150" height="150" /></a>Acta Neurochir (2011) 153:479–487. DOI 10.1007/s00701-010-0911-3</strong></p>
<p style="text-align: justify;">Complete resection of grade II gliomas might prolong survival but is not always possible. The goal of the study was to evaluate the location of unexpected grade II gliomas remnants after assumed complete removal with intraoperative (iop) MRI and to assess the reason for their non-detection.</p>
<p style="text-align: justify;">Methods Intraoperative MR images of 35 patients with hemispheric grade II gliomas, acquired after assumed complete removal of preoperatively segmented tumor/ tumor part, were studied for existence of unexpected tumor remnants. Remnants location was classified in relation to tumor cavity in axial and vertical planes. The relation of remnants to retractor position and to surgeons’ visual axis, and the role of neuronavigational accuracy and brain shift, was assessed.</p>
<p style="text-align: justify;">Results Unexpected remnants were found in 16 patients (46%). In 29.2%, the reason was loss of neuronavigational accuracy. In 21%, remnants were in that part of the resection cavity, where the retractor had been placed initially. In 17%, they were deeply located and hidden by the retractor. In 13%, remnants were hidden by the overlapping brain; and in 21%, the reason was not obvious. In 75% of all temporomesial tumors, remnants were posterolateral to the resection cavity. Remnants detection with iopMRI and update of neuronavigational data allowed further removal in 14 of 16 cases. In two cases, remnant location precluded their removal.</p>
<p style="text-align: justify;">Conclusions Distribution of tumor remnants of grade II gliomas tends to follow some patterns. Targeted attention to the areas of possible remnants could increase the radicality of surgery, even if intraoperative imaging is not performed.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2316/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cervical Facet Degeneration After Total Disc Replacement: 280 Levels in 162 Patients: 5-Year Follow-up</title>
		<link>http://www.neurosurgery-blog.com/archives/2206</link>
		<comments>http://www.neurosurgery-blog.com/archives/2206#comments</comments>
		<pubDate>Mon, 14 Feb 2011 05:00:25 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Spine]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Cervical spine]]></category>
		<category><![CDATA[facet degeneration]]></category>
		<category><![CDATA[facet disease]]></category>
		<category><![CDATA[porous coated motion]]></category>
		<category><![CDATA[Total disc replacement]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2206</guid>
		<description><![CDATA[Neurosurg Q 2011;21:17–21. 
Much information and classifications of lumbar facet joint degeneration after lumbar total disc replacement are available, but nowadays in the cervical spine this concept is unstudied.
Analyzing our experience, we propose a computed tomography (CT) scan classification to evaluate degenerative facet joint disease after cervical arthroplasty. After 5-year follow-up for total disc replacement [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/02/facetdeg.jpg"><img class="alignleft size-thumbnail wp-image-2207" title="facetdeg" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/02/facetdeg-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurg Q 2011;21:17–21. </strong></p>
<p style="text-align: justify;">Much information and classifications of lumbar facet joint degeneration after lumbar total disc replacement are available, but nowadays in the cervical spine this concept is unstudied.</p>
<p style="text-align: justify;">Analyzing our experience, we propose a computed tomography (CT) scan classification to evaluate degenerative facet joint disease after cervical arthroplasty. After 5-year follow-up for total disc replacement in a consecutive series of 162 patients (44.5±8.6-y-old) with a total of 280 Porous Coated Motion total cervical disc replacement from C3-4 to C7-T1, we analyzed the facet degeneration in 4 grades using CT scan, and compared with preoperative images. CT scans, x-rays, and clinical outcomes were collected preoperatively and postoperatively after 3 and 6 months, and annually after 12-month follow-up. The Neck Disability Index and Visual Analog Scale were used to assess pain and functional outcomes.</p>
<p style="text-align: justify;">From all operated levels, we found 8.57% (24 levels) of degenerated facets. On the basis of the proposed classification, 50% (12 levels) of all degenerated levels had grade I, 37.5% (9 levels) with grade II, 8.3% (2 levels) with grade III, and 4.16% (1 level) had grade IV of facet degeneration. In patients with grades III and IV, it was possible to observe a worsening in Visual Analog Scale outcome assessment.</p>
<p style="text-align: justify;">Facet joint degeneration is a possible consequence of cervical disc arthroplasty, despite its low rate occurrence. We did not find relationship between the early grades of CT observed facet degeneration and clinical results, but in grades III and IV there was correlation. A CT scan classification to evaluate cervical degenerative facet joint disease is essential to better understand and report this spinal phenomenon.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2206/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Decision analysis of treatment options for vestibular schwannoma</title>
		<link>http://www.neurosurgery-blog.com/archives/2172</link>
		<comments>http://www.neurosurgery-blog.com/archives/2172#comments</comments>
		<pubDate>Mon, 07 Feb 2011 05:00:00 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[radiosurgery]]></category>
		<category><![CDATA[Acoustic neuroma]]></category>
		<category><![CDATA[decision analysis]]></category>
		<category><![CDATA[radiosurgery • microsurgery]]></category>
		<category><![CDATA[Vestibular schwannoma]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2172</guid>
		<description><![CDATA[J Neurosurg 114:400–413, 2011. (DOI: 10.3171/2010.3.JNS091802)
Widespread use of MR imaging has contributed to the more frequent diagnosis of vestibular schwannomas (VSs). These tumors represent 10% of primary adult intracranial neoplasms, and if they are symptomatic, they usually present with hearing loss and tinnitus. Currently, there are 3 treatment options for quality of life (QOL): wait [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/02/VS.jpg"><img class="alignleft size-thumbnail wp-image-2175" title="VS" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/02/VS-150x150.jpg" alt="" width="150" height="150" /></a>J Neurosurg 114:400–413, 2011. (DOI: 10.3171/2010.3.JNS091802)</strong></p>
<p style="text-align: justify;">Widespread use of MR imaging has contributed to the more frequent diagnosis of vestibular schwannomas (VSs). These tumors represent 10% of primary adult intracranial neoplasms, and if they are symptomatic, they usually present with hearing loss and tinnitus. Currently, there are 3 treatment options for quality of life (QOL): wait and scan, microsurgery, and radiosurgery. In this paper, the authors’ purpose is to determine which treatment modality yields the highest QOL at 5- and 10-year follow-up, considering the likelihood of recurrence and various complications.</p>
<p style="text-align: justify;">Methods. The MEDLINE, Embase, and Cochrane online databases were searched for English-language articles published between 1990 and June 2008, containing key words relating to VS. Data were pooled to calculate the prevalence of treatment complications, tumor recurrence, and QOL with various complications. For parameters in which incidence varied with time of follow-up, the authors used meta-regression to determine the mean prevalence rates at a specified length of follow-up. A decision-analytical model was constructed to compare 5- and 10-year outcomes for a patient with a unilateral tumor and partially intact hearing. The 3 treatment options, wait and scan, microsurgery, and radiosurgery, were compared.</p>
<p style="text-align: justify;">Results. After screening more than 2500 abstracts, the authors ultimately included 113 articles in this analysis. Recurrence, complication rates, and onset of complication varied with the treatment chosen. The relative QOL at the 5-year follow-up was 0.898 of normal for wait and scan, 0.953 for microsurgery, and 0.97 for radiosurgery. These differences are significant (p &lt; 0.0052). Data were too scarce at the 10-year follow-up to calculate significant differences between the microsurgery and radiosurgery strategies.</p>
<p style="text-align: justify;">Conclusions. At 5 years, patients treated with radiosurgery have an overall better QOL than those treated with either microsurgery or those investigated further with serial imaging. The authors found that the complications associated with wait-and-scan and microsurgery treatment strategies negatively impacted patient lives more than the complications from radiosurgery. One limitation of this study is that the 10-year follow-up data were too limited to analyze, and more studies are needed to determine if the authors’ results are still consistent at 10 years.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2172/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Microsurgery for Previously Coiled Aneurysms: Experience With 81 Patients</title>
		<link>http://www.neurosurgery-blog.com/archives/2048</link>
		<comments>http://www.neurosurgery-blog.com/archives/2048#comments</comments>
		<pubDate>Tue, 11 Jan 2011 05:00:47 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Vascular]]></category>
		<category><![CDATA[Bypass]]></category>
		<category><![CDATA[Coiled aneurysm]]></category>
		<category><![CDATA[Incomplete coiling]]></category>
		<category><![CDATA[Microsurgical technique]]></category>
		<category><![CDATA[Proximal occlusion]]></category>
		<category><![CDATA[Subarachnoid hemorrhage]]></category>
		<category><![CDATA[Surgical video]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2048</guid>
		<description><![CDATA[Neurosurgery 68:140–154, 2011 DOI: 10.1227/NEU.0b013e3181fd860e
Residual and recurrent intracranial aneurysms after endovascular treatment with Guglielmi detachable coils may necessitate a microsurgical occlusion.
OBJECTIVE: To analyze the microsurgical technique and describe how the location, morphology, and appearance of the coiled aneurysm affect the technique.
METHODS: We retrospectively analyzed 81 patients with 82 previously coiled aneurysms treated microsurgically at 2 [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/01/coiledaneurysm.jpg"><img class="alignleft size-thumbnail wp-image-2050" title="coiledaneurysm" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/01/coiledaneurysm-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurgery 68:140–154, 2011 DOI: 10.1227/NEU.0b013e3181fd860e</strong></p>
<p style="text-align: justify;">Residual and recurrent intracranial aneurysms after endovascular treatment with Guglielmi detachable coils may necessitate a microsurgical occlusion.</p>
<p style="text-align: justify;">OBJECTIVE: To analyze the microsurgical technique and describe how the location, morphology, and appearance of the coiled aneurysm affect the technique.</p>
<p style="text-align: justify;">METHODS: We retrospectively analyzed 81 patients with 82 previously coiled aneurysms treated microsurgically at 2 Finnish neurosurgical university hospitals in Helsinki and Kuopio between July 1995 and August 2009. Seven videos were selected to demonstrate the microsurgical strategy in various locations.</p>
<p style="text-align: justify;">RESULTS: Fifty-eight aneurysms (71%) were located at anterior circulation and 24 (29%) at posterior circulation. Fifteen patients were operated on within the first month (early surgery) after coiling, whereas 66 were treated later (late surgery). Complete or partial removal of coils during surgery may facilitate clipping, but is significantly (P, .001) more difficult to accomplish in late surgery. Removal of coils may also increase the chance of poor outcome. Chance of poor outcome also increased with intraoperative aneurysm rupture, size of the aneurysm, and posterior circulation location. Good clinical outcome (same or better clinical condition 3 months after surgery) was achieved in 71 patients (88%). After microsurgery, 4 patients were severely disabled and 6 patients died, 3 of them because of poor clinical condition.</p>
<p style="text-align: justify;">CONCLUSION: Complete microsurgical occlusion of the residual aneurysm is possible. However, in large or giant aneurysms direct microsurgery is a challenging high-risk procedure, and we recommend that these patients be referred to a dedicated neurovascular center to minimize surgical complications. Even in experienced hands, use of different bypass procedures may be the best option for demanding growing lesions, especially those in the posterior circulation.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2048/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Skull base tumor model. Laboratory investigation</title>
		<link>http://www.neurosurgery-blog.com/archives/1828</link>
		<comments>http://www.neurosurgery-blog.com/archives/1828#comments</comments>
		<pubDate>Fri, 19 Nov 2010 05:00:37 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[endoscopic approach]]></category>
		<category><![CDATA[Microsurgery]]></category>
		<category><![CDATA[skull base]]></category>
		<category><![CDATA[skull base approach]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[training model]]></category>
		<category><![CDATA[tumor model]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1828</guid>
		<description><![CDATA[J Neurosurg 113:1106–1111, 2010. DOI: 10.3171/2010.3.JNS09513
Resident duty-hours restrictions have now been instituted in many countries worldwide. Shortened training times and increased public scrutiny of surgical competency have led to a move away from the traditional apprenticeship model of training. The development of educational models for brain anatomy is a fascinating innovation allowing neurosurgeons to train [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/11/Skullbasemodel.jpg"><img class="alignleft size-thumbnail wp-image-1829" title="Skullbasemodel" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/11/Skullbasemodel-150x150.jpg" alt="" width="120" height="120" /></a>J Neurosurg 113:1106–1111, 2010. DOI: 10.3171/2010.3.JNS09513</strong></p>
<p style="text-align: justify;">Resident duty-hours restrictions have now been instituted in many countries worldwide. Shortened training times and increased public scrutiny of surgical competency have led to a move away from the traditional apprenticeship model of training. The development of educational models for brain anatomy is a fascinating innovation allowing neurosurgeons to train without the need to practice on real patients and it may be a solution to achieve competency within a shortened training period. The authors describe the use of Stratathane resin ST-504 polymer (SRSP), which is inserted at different intracranial locations to closely mimic meningiomas and other pathological entities of the skull base, in a cadaveric model, for use in neurosurgical training.</p>
<p style="text-align: justify;">Methods. Silicone-injected and pressurized cadaveric heads were used for studying the SRSP model. The SRSP presents unique intrinsic metamorphic characteristics: liquid at first, it expands and foams when injected into the desired area of the brain, forming a solid tumorlike structure. The authors injected SRSP via different passages that did not influence routes used for the surgical approach for resection of the simulated lesion. For example, SRSP injection routes included endonasal transsphenoidal or transoral approaches if lesions were to be removed through standard skull base approach, or, alternatively, SRSP was injected via a cranial approach if the removal was planned to be via the transsphenoidal or transoral route. The model was set in place in 3 countries (US, Italy, and The Netherlands), and a pool of 13 physicians from 4 different institutions (all surgeons and surgeons in training) participated in evaluating it and provided feedback.</p>
<p style="text-align: justify;">Results. All 13 evaluating physicians had overall positive impressions of the model. The overall score on 9 components evaluated—including comparison between the tumor model and real tumor cases, perioperative requirements, general impression, and applicability—was 88% (100% being the best possible achievable score where the evaluator strongly agreed with the proposed factor). Individual components had scores at or above 80% (except for 1). The only score that was below 80% was related to radiographic visibility of the model for adequate surgical planning (score of 74%). The highest score was given to usefulness in neurosurgical training (98%).</p>
<p style="text-align: justify;">Conclusions. The skull base tumor model is an effective tool to provide more practice in preoperative planning and technical skills.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1828/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Utility of diffusion tensor-imaged (DTI) motor fiber tracking for the resection of intracranial tumors near the corticospinal tract</title>
		<link>http://www.neurosurgery-blog.com/archives/1760</link>
		<comments>http://www.neurosurgery-blog.com/archives/1760#comments</comments>
		<pubDate>Tue, 02 Nov 2010 05:00:32 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Neuronavigation]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[DTI fiber tracking]]></category>
		<category><![CDATA[Glioma surgery]]></category>
		<category><![CDATA[Image guidance]]></category>
		<category><![CDATA[Intraoperative neuromonitoring (IONM)]]></category>
		<category><![CDATA[Tumor resection]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1760</guid>
		<description><![CDATA[Acta Neurochir. DOI 10.1007/s00701-010-0817-0
Treatment of intracranial tumors near the corticospinal tract remains a surgical challenge. Several technical tools to map and monitor the motor tract have been implemented. The present study aimed to assess the utility of diffusion tensor imaging (DTI) fiber tracking in the surgical treatment of motor eloquent tumors at our institution.
Methods Patients [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/11/CStract.jpg"><img class="alignleft size-thumbnail wp-image-1761" title="CStract" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/11/CStract-150x150.jpg" alt="" width="150" height="150" /></a>Acta Neurochir. DOI 10.1007/s00701-010-0817-0</strong></p>
<p style="text-align: justify;">Treatment of intracranial tumors near the corticospinal tract remains a surgical challenge. Several technical tools to map and monitor the motor tract have been implemented. The present study aimed to assess the utility of diffusion tensor imaging (DTI) fiber tracking in the surgical treatment of motor eloquent tumors at our institution.</p>
<p style="text-align: justify;">Methods Patients operated for intracranial tumors close to the motor tract with the use of intraoperative image guidance including DTI fiber tracking of the corticospinal tract and intraoperative motor evoked potential (MEP) monitoring were analyzed. The intraoperative utility of fiber tracking data was analyzed. Furthermore, preoperative MRI scans with and without motor fiber tracking were reevaluated post hoc for tumor relation to the motor tract, estimated resectability, and best approach. Thereby, the utility of fiber tracking in surgical planning was assessed.</p>
<p style="text-align: justify;">Results Nineteen patients were analyzed. The estimation of tumor localization in relation to the motor tract and of resectability was not influenced by fiber tracking in any of the cases. Only in one single case did evaluating surgeons change their surgical approach after the addition of the fiber tracking data. In all cases, fiber tracking included in image guidance did not change the intraoperative strategy, while MEP monitoring did.</p>
<p style="text-align: justify;">Conclusions DTI fiber tracking did not influence the surgical planning or the intraoperative course. However, it is still used at our institution due to its ease in acquisition and its potential impact in a larger series. Furthermore, more experience with this technique is required to lead to a technical improvement.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1760/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas</title>
		<link>http://www.neurosurgery-blog.com/archives/1706</link>
		<comments>http://www.neurosurgery-blog.com/archives/1706#comments</comments>
		<pubDate>Wed, 20 Oct 2010 04:00:28 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[5-aminolevulinic acid]]></category>
		<category><![CDATA[Fluorescence]]></category>
		<category><![CDATA[meningioma]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1706</guid>
		<description><![CDATA[Acta Neurochir (2010) 152:1711–1719. DOI 10.1007/s00701-010-0708-4
5-aminolevulinic acid (5-ALA) has gained importance as an intraoperative photodynamic diagnostic agent for the extirpation of malignant gliomas. The application of this technique for resection of meningiomas has barely been explored. The aim of this study was to evaluate the utility of 5-ALA-induced fluorescence as a visual tool in meningioma [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/10/meningioma.fluor_.jpg"><img class="alignleft size-thumbnail wp-image-1707" title="meningioma.fluor" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/10/meningioma.fluor_-150x150.jpg" alt="" width="120" height="120" /></a>Acta Neurochir (2010) 152:1711–1719. DOI 10.1007/s00701-010-0708-4</strong></p>
<p style="text-align: justify;">5-aminolevulinic acid (5-ALA) has gained importance as an intraoperative photodynamic diagnostic agent for the extirpation of malignant gliomas. The application of this technique for resection of meningiomas has barely been explored. The aim of this study was to evaluate the utility of 5-ALA-induced fluorescence as a visual tool in meningioma resection and its correlation with histological findings.</p>
<p style="text-align: justify;">Methods A total of 33 consecutive patients undergoing resection of intracranial meningiomas from December 2007 to August 2009 were included in this study. After confirmation of normal liver function, 5-ALA was administered orally (20 mg/kg) within 3–5 h prior to skin incision. All cases were operated on using standard microsurgical and neuronavigation-guided techniques. Intraoperative 440 nm fluorescence was applied periodically during and at the end of resection in order to detect tumor-infiltrated sites. The fluorescence of the tumor was evaluated intraoperatively by the surgeon and confirmed by subsequent video analysis.</p>
<p style="text-align: justify;">Results A total of 32 (97%) patients presented with benign meningiomas (WHO I–II). In 1 (3%) patient, histological anaplastic signs (WHO III) could be demonstrated. 5-ALAinduced fluorescence of the tumor was confirmed in a total of 31 (94%) patients. The fluorescence did not correlate with the histological findings (n=30 WHO I–II, n=1 WHO grade III) or with preoperative brain edema and administration of steroids. A total resection could be postoperatively demonstrated in 25 (76%) patients. No adverse effects attributable to 5-ALA occurred.</p>
<p style="text-align: justify;">Conclusions 5-ALA-induced fluorescence is a useful and promising intraoperative tool for the visualization of meningioma tissue. The novel findings demonstrated in this study in terms of high fluorescence and poor correlation with histological findings highlight the usefulness of this technique as a routine visual tool to achieve optimal resection of meningiomas.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1706/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Treatment of Intracranial Aneurysms by Functional Reconstruction of the Parent Artery: The Budapest Experience with the Pipeline Embolization Device</title>
		<link>http://www.neurosurgery-blog.com/archives/1313</link>
		<comments>http://www.neurosurgery-blog.com/archives/1313#comments</comments>
		<pubDate>Mon, 26 Jul 2010 04:00:32 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Vascular]]></category>
		<category><![CDATA[Aneurysm]]></category>
		<category><![CDATA[angiographic occlusion]]></category>
		<category><![CDATA[endoluminal sleeve]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1313</guid>
		<description><![CDATA[Am J Neuroradiol 31:1139–47. DOI 10.3174/ajnr.A2023
Aneurysm treatment by intrasacular packing has been associated with a relatively high rate of recurrence. The use of mesh tubes has recently gained traction as an alternative therapy. This article summarizes the midterm results of using an endoluminal sleeve, the PED, in the treatment of aneurysms.
MATERIALS AND METHODS: A total [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/07/giantaneurysm.jpg"><img class="alignleft size-full wp-image-1316" title="giantaneurysm" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/07/giantaneurysm.jpg" alt="" width="115" height="104" /></a>Am J Neuroradiol 31:1139–47. DOI 10.3174/ajnr.A2023</p>
<p style="text-align: justify;">Aneurysm treatment by intrasacular packing has been associated with a relatively high rate of recurrence. The use of mesh tubes has recently gained traction as an alternative therapy. This article summarizes the midterm results of using an endoluminal sleeve, the PED, in the treatment of aneurysms.</p>
<p style="text-align: justify;">MATERIALS AND METHODS: A total of 19 wide-neck aneurysms were treated in 18 patients: 10 by implantation of PEDs alone and 9 by a combination of PED and coils. Angiographic and clinical results were recorded immediately and at 6 months following treatment.</p>
<p style="text-align: justify;">RESULTS: Immediate angiographic occlusion was achieved in 4 and flow reduction, in another 15 aneurysms. Angiography at 6 months demonstrated complete occlusion in 17 and partial filling in 1 of 18 patients. There was no difference between coil-packed and unpacked aneurysms. Of 28 side branches covered by 1 device, the ophthalmic artery was absent immediately in 1 and at 6 months in another 2 cases. One patient experienced abrupt in-stent thrombosis resulting in a transient neurologic deficit, and 1 patient died due to rupture of a coexisting aneurysm. All giant aneurysms treated with PED alone were demonstrated by follow-up cross-sectional imaging to have involuted by 6 months.</p>
<p style="text-align: justify;">CONCLUSIONS: Treatment of large, wide-neck, or otherwise untreatable aneurysms with functional reconstruction of the parent artery may be achieved with relative safety using dedicated flowmodifying devices with or without adjunctive use of intrasaccular coil packing.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1313/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Endoscopic endonasal transclival resection of chordomas: operative technique, clinical outcome, and review of the literature</title>
		<link>http://www.neurosurgery-blog.com/archives/1001</link>
		<comments>http://www.neurosurgery-blog.com/archives/1001#comments</comments>
		<pubDate>Tue, 18 May 2010 04:00:06 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Chordoma]]></category>
		<category><![CDATA[clivus]]></category>
		<category><![CDATA[Endoscopy]]></category>
		<category><![CDATA[minimally invasive]]></category>
		<category><![CDATA[skull base surgery]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=1001</guid>
		<description><![CDATA[J Neurosurg 112:1061–1069, 2010. DOI: 10.3171/2009.7.JNS081504
Transcranial approaches to clival chordomas provide a circuitous route to the site of origin of the tumor often involving extensive bone drilling and brain retraction, which places critical neurovascular structures between the surgeon and pathology. For certain chordomas, the endonasal endoscopic transclival approach is a novel minimal access, but it [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: left;"><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2010/05/Chordoma.jpg"><img class="alignleft size-thumbnail wp-image-1002" title="Chordoma" src="http://www.neurosurgery-blog.com/wp-content/uploads/2010/05/Chordoma-150x150.jpg" alt="" width="120" height="120" /></a>J Neurosurg 112:1061–1069, 2010. DOI: 10.3171/2009.7.JNS081504</p>
<p style="text-align: justify;">Transcranial approaches to clival chordomas provide a circuitous route to the site of origin of the tumor often involving extensive bone drilling and brain retraction, which places critical neurovascular structures between the surgeon and pathology. For certain chordomas, the endonasal endoscopic transclival approach is a novel minimal access, but it is an equally aggressive alternative providing the most direct route to the tumor epicenter.</p>
<p style="text-align: justify;">Methods. The authors present a consecutive series of patients undergoing endonasal endoscopic resection of clival chordomas. Extent of resection was determined by postoperative volumetric MR imaging and divided into &gt; 95% and &lt; 95%.</p>
<p style="text-align: justify;">Results. Seven patients underwent 10 operations. Preoperative cranial neuropathies were present in 4. The mean patient age was 52.0 years. The mean tumor volume was 34.9 cm3. Intraoperative lumbar drainage was used in 1 patient, and the tumors extended intradurally in 3. One patient underwent 2 intentionally palliative procedures for subtotal debulking. Greater than 95% resection was achieved in 7 of 8 operations in which radical resection was the goal (87%). All tumors with volumes &lt; 50 cm3 had &gt; 95% resection (p = 0.05). The overall mean follow-up was 18.0 months. Cranial neuropathies resolved in all 3 patients with cranial nerve VI palsies. One patient with recurrent nasopharyngeal chordoma died of disease progression; another experienced 2 recurrences before receiving radiation therapy. All surviving patients remain progression free. There were no intraoperative complications; however, 1 patient developed a pulmonary embolus postoperatively. There were no postoperative CSF leaks.</p>
<p style="text-align: justify;">Conclusions. The endonasal endoscopic transclival approach represents a less invasive and more direct approach than a transcranial approach to treat certain moderate-sized midline skull base chordomas. Longer follow-up is necessary to determine comparability to transcranial approaches for long-term control. Large tumors with significant extension lateral to the carotid artery may not be suitable for this approach.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/1001/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

